催产素市场 - 按适应症（产前、产后）、配销通路（医院药房、零售药房、线上药房）- 全球预测（2024 - 2032）

Oxytocin Market - By Indication (Antepartum, Postpartum), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)- Global Forecast (2024 - 2032)

出版日期: 2024年04月29日 | 出版商:

Global Market Insights Inc. | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

简介目录

在老年人口快速成长的推动下，全球催产素市场规模预计 2024 年至 2032 年复合年增长率将达到 9.5%。研究人员正在探索催产素在传统用途之外的扩展应用，以增强老年人的社会连结和情绪健康。透过不断的探索，催产素在满足老龄化社会不断变化的需求方面发挥着重要作用，为支持老年人照护和福祉提供了新途径。

正在进行的研究也推动了产品在老年保健领域的应用，以提供针对老龄化人口的特定挑战的新颖治疗方法。根据《2022年世界人口展望》，65岁以上人口的成长速度快于该年龄以下人口的成长速度。这一趋势凸显了催产素研究在满足老龄化人口的特定需求方面日益重要。

整个市场分为适应症、配销通路和地区。

就迹象而言，由于在身体准备分娩方面的作用日益增强，预计产前催产素产业从 2024 年到 2032 年将录得显着的复合年增长率。在怀孕期间，身体会自然产生催产素来刺激子宫收缩并促进分娩。因此，医疗保健提供者在必要时使用合成催产素来引产或增加分娩。此外，正在进行的研究正在试图了解如何优化催产素的给药以确保安全有效的引产和管理。

从配销通路来看，线上药局催产素产业预计将在 2024 年至 2032 年期间成长。这些平台还提供用于医疗目的的催产素，例如引产和产后出血的治疗。随着科技的进步，网路药局正在改善医疗保健的可近性，特别是对于催产素等对孕产妇和生殖健康至关重要的药物。

从地区来看，在辅助生殖应用不断扩大和药物传递方法进步的推动下，亚太地区催产素市场规模预计将在 2024 年至 2032 年间呈现强劲增长。该地区的医疗保健提供者正在利用催产素来提高生育治疗的效果并有效地管理分娩。用于优化催产素给药、提高其在生殖保健中的功效和安全性的给药技术的持续进步将推动该产品在亚太地区的使用。

产业生态系统分析
产业影响力
- 成长动力
- 妊娠併发症发生率上升
- 生育率增加
- 人们对引产和母乳哺育的认识不断提高
- 增加研发活动
- 产业陷阱与挑战
- 严格的监管要求
- 药费高
成长潜力分析
管道分析
监管环境
技术景观
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
主要市场参与者的竞争分析
竞争定位矩阵
战略展望矩阵

第 5 章：市场估计与预测：按指标划分，2021 - 2032 年

主要趋势
产前
产后

第 6 章：市场估计与预测：按配销通路划分，2021 - 2032 年

主要趋势
医院药房
零售药局
网路药局

第 7 章：市场估计与预测：按地区，2021 - 2032

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 沙乌地阿拉伯
- 南非
- 阿联酋
- 中东和非洲其他地区

第 8 章：公司简介

Endo International plc
Ferring Pharmaceuticals
Fresenius SE & Co. KGaA
Hikma Pharmaceuticals PLC
Novartis AG
Pfizer Inc.
Sun Pharma Industries Limited.
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
Wockhardt Limited
Yuhan Corporation

简介目录

Product Code: 9261

Global Oxytocin Market size is projected to record 9.5% CAGR from 2024 to 2032, driven by the rapid growth of the geriatric population. Researchers are exploring expanded applications of oxytocin beyond conventional uses for enhancing social bonding and emotional well-being among older adults. With this ongoing exploration, oxytocin is playing a significant role in meeting the evolving needs of the aging society for offering new avenues for supporting elderly care and well-being.

The ongoing research is also driving the product application in geriatric healthcare for providing novel therapeutic approaches tailored to specific challenges of the aging population. According to the World Population Prospects 2022, the population above the age of 65 years is growing more rapidly than the population below that age. This trend is underscoring the increasing relevance of oxytocin research in addressing the specific needs of the aging demographic.

The overall market is segregated into indication, distribution channel, and region.

In terms of indication, the oxytocin industry from the antepartum segment is expected to record significant CAGR from 2024 to 2032, driven by the increasing role in preparing the body for childbirth. During pregnancy, the body naturally produces oxytocin to stimulate uterine contractions and facilitate labor. Hence, healthcare providers are using synthetic oxytocin to induce or augment labor when necessary. In addition, ongoing studies are trying to understand how oxytocin administration can be optimized to ensure safe and effective labor induction and management.

By distribution channel, the oxytocin industry from the online pharmacies segment is projected to rise from 2024 to 2032. Online pharmacies offer oxytocin for providing convenient access for patients seeking the hormone. These platforms are also supplying oxytocin for medical purposes, such as labor induction and management of postpartum hemorrhage. With technological advances, online pharmacies are improving healthcare accessibility, especially for medications like oxytocin that are critical in maternal and reproductive health.

Regionally, the Asia Pacific oxytocin market size is projected to exhibit robust growth between 2024 and 2032, fueled by the expanding applications in assisted reproduction and advancements in drug delivery methods. Healthcare providers in the region are utilizing oxytocin to enhance outcomes in fertility treatments and manage labor effectively. The ongoing advancements in drug delivery technologies for optimizing the administration of oxytocin for improving its efficacy and safety profiles in reproductive health care will drive the product uptake in APAC.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.2 Rising incidence of pregnancy complications
- 3.2.3 Increase in childbirth rates
- 3.2.4 Growing awareness of induced labor and breastfeeding
- 3.2.5 Increasing research & development activities
- 3.2.6 Industry pitfalls & challenges
- 3.2.7 Stringent regulatory requirements
- 3.2.8 High cost of drug
3.3 Growth potential analysis
3.4 Pipeline analysis
3.5 Regulatory landscape
3.6 Technological landscape
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Indication, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Antepartum
5.3 Postpartum

Chapter 6 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Hospital pharmacies
6.3 Retail pharmacies
6.4 Online pharmacies

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
- 7.3.7 Rest of Europe
7.4 Asia Pacific
- 7.4.1 Japan
- 7.4.2 China
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 Middle East and Africa
- 7.6.1 Saudi Arabia
- 7.6.2 South Africa
- 7.6.3 UAE
- 7.6.4 Rest of Middle East and Africa